AFGFX
Price
$81.79
Change
-$0.09 (-0.11%)
Updated
Nov 13 closing price
GFACX
Price
$70.91
Change
-$0.13 (-0.18%)
Updated
Nov 13 closing price
Ad is loading...

AFGFX vs GFACX

Header iconAFGFX vs GFACX Comparison
Open Charts AFGFX vs GFACXBanner chart's image
Virtus Silvant Focused Growth R6
Price$81.79
Change-$0.09 (-0.11%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$70.91
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
AFGFX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AFGFX vs. GFACX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFGFX is a Buy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 306B vs. AFGFX (1.52B). AFGFX (0.00) and GFACX (0.00) have matching dividends . AFGFX was incepted earlier than GFACX: AFGFX (9 years) vs GFACX (24 years). AFGFX is a more actively managed with annual turnover of: 65.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than AFGFX: GFACX (250) vs AFGFX (2500000). AFGFX annual gain was more profitable for investors over the last year : 43.14 vs. GFACX (29.12). AFGFX return over 5 years is better than : 58.11 vs. GFACX (48.44).
AFGFXGFACXAFGFX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD39.90828.927138%
Front LoadN/AN/A-
Min. Initial Investment25000002501,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.52B306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year43.1429.12148%
Returns for 3 years3.66-5.45-67%
Returns for 5 years58.1148.44120%
Returns for 10 yearsN/A58.85-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSW19.31N/A
N/A
OneSpaWorld Holdings Limited
CBT110.95-1.59
-1.41%
Cabot Corp
WMB55.60-1.14
-2.01%
Williams Companies
VCIG1.52-0.16
-9.52%
VCI Global Limited
PSTX3.27-0.42
-11.38%
Poseida Therapeutics